Spirulina Significantly Reduces COVID-19 Mortality: Study
Hospitalized COVID-19 patients who took spirulina had a lower risk of death than those who did not, according to the results of a randomized controlled trial recently published in Frontiers in Immunology. Study participants took spirulina for six days. No deaths were recorded in the spirulina group, while 15 percent of those who only received standard treatment died. “The overall results of the present study showed that a six-day course of Spirulina platensis plus the standard treatment of COVID-19 was superior in the recovery of patients compared to standard treatment alone,” the authors wrote. The study was conducted at two Iranian hospitals, where 189 patients were randomized to take 15.2 grams of spirulina capsules alongside standard COVID-19 treatment or only receive standard treatment. Previous research showed that this dosage of spirulina would provide potent anti-inflammatory and antioxidative effects. In both the experimental and control groups, half of the patients were in t